Abstract:
PURPOSE: A novel [6+5]fused bicycle derivative and a pharmaceutical composition containing the same are provided to be used as a therapeutic agent for treating platelet aggregation, arteriosclerosis, vascular restenosis, blood clotting, and hypertension. CONSTITUTION: A novel [6+5]fused bicycle derivative is denoted by chemical formula 1. A method for preparing the composition of chemical formula 1 comprises a step of reacting compounds of chemical formulas 2 and 3 or reacting compounds of chemical formulas 4 and 5. A PAR-1 antagonist composition contains the compound of chemical formula 1, pharmaceutically acceptable salt thereof, or pharmaceutically acceptable carrier.
Title translation:7-(3',4'-二烷氧基苯基) - [1,2,4] - 三唑并[1,5-A]吡啶化合物,其制备方法和药物组合物,用于治疗或预防哮喘,慢性阻塞性肺动脉疾病, ARTHRITIS,ATOPIC DERMATITIS,TUMOR AND DEGENERATIVE BRAIN DISEASES COMPATH THE SAME
Abstract:
A 7-(3',4'-dialkoxyphenyl)-[1,2,4]-triazolo[1,5-a]pyrimidine compound is provided to show excellent activity on PDE-4 enzymes and high selectivity on other PDE enzymes and improve vomiting related side effects, which is one most serious problem of the PDE-4 inhibitors, thereby being used as a therapeutic agent of asthma and chronic obstructive pulmonary diseases, arthritis, atopic dermatitis, leukemia, cancer and brain diseases. A 7-(3',4'-dialkoxyphenyl)-[1,2,4]-triazolo[1,5-a]pyrimidine compound is represented by a formula(1) and is prepared by reacting 3-amino-triazole compound represented by a formula(4) with 3-(dimethylamino)-1-(3,4-dialkoxyphenyl)prophenone compound represented by a formula(5) or 3-(3,4-dialkoxyphenyl)3-oxopropionealdehyde compound represented by a formula(6) in the presence of acetic acid. In the formulae, each R1 and R2 is independently H, linear or branched saturated or unsaturated C1-7 alkyl, linear or branched saturated or unsaturated C1-7 alkyl including O, N or S, C3-7 cycloalkyl, C3-7 cycloalkyl including O, N or S, (C3-7)cycloalkyl(C1-7)alkyl, 3 to 7-membered saturated or unsaturated heterocycloalkyl including O, N, or S in a heterocycle, phenyl or benzyl, or R1 and R2 may be linked to each other by C1-3 alkylene or C1-3 alkylene including halogen; R3 is aryl selected from groups(1) to (4). A pharmaceutical composition for treating or preventing diseases related to bronchial inflammation such as asthma and chronic obstructive pulmonary disease, arthritis, atopic dermatitis, leukemia, cancer and brain diseases such as Alzheimer's disease, depression and memory decrease comprises the 7-(3',4'-dialkoxyphenyl)-[1,2,4]-triazolo[1,5-a]pyrimidine compound or a pharmaceutically acceptable carrier as an effective ingredient.
Abstract:
A novel pyrazole compound is provided to show excellent inhibitory activity on PDE-4 enzyme, thereby being used in order to prevent and treat asthma, chronic obstructive pulmonary disease, arthritis, atopic dermatitis, tumor and degenerative brain diseases. A 1-(3,4-dialkoxybenzyl)-1H-pyrazole compound is represented by the formula(1), wherein each R1 and R2 is independently H, linear or branched C1-7 alkyl, linear or branched C1-7 C1-7 alkyl including halogen, C3-7 cycloalkyl, (C3-7)cycloalkyl(C1-7)alkyl, 3- to 7-membered heterocycloalkyl including O, N or S in a hetero-cycle, 3- to 7-membered heterocycloalkyl(C1-7)alkyl including O, N or S in a hetero-cycle, phenyl, benzyl or allyl, or R1 and R2 may be linked to each other with C1-3 alkylene or C1-3 alkylene including halogen; R3 is H, formyl, halogen, linear or branched C1-10 alkyl, C1-10 alkoxy, C3-7 cycloalkyl, (C1-7)alkoxy(C1-7)alkyl, C1-7 alkyl ketone, (C3-7)cycloalkyl(C1-7)alkyl, (C3-7)cycloalkyl(C1-7)alkoxy, (C1-10)alkylcarboxylic acid, carboxyl(C1-10)alkylester, carboxyl(C1-10)alkylamide, amino, mono or di(C1-7)alkylamino, mono or di(C1-7)alkylaminocarbonyl; (C3-7)cycloalkylamino, morpholine, morpholine oxide, piperidine, piperazine, piperazine oxide, cyano, nitro, carboxylic acid guanidine, urea, phenoxy, benzyloxy, or an Aryl represented by the group(I); each R4 and R5 is independently H, halogen, formyl, linear or branched C1-10 alkyl, C1-10 alkoxy, (C1-10)alkoxy(C1-10)alkyl, C1-7 alkylketone, hydroxy(C1-10)alkyl, C3-7 cycloalkyl, (C3-7)cycloalkyl(C1-7)alkyl, (C3-7)cycloalkyl(C1-7)alkoxy, carboxylic acid, carboxyl(C1-10)alkylester, carboxyl(C1-10)alkylamide, amino, mono or di(C1-7)alkylamino, mono or di(C1-7)alkylaminocarbonyl, phenyl, phenoxy, benzyl, benzyloxy, 3- to 7-membered heterocycloalkyl including O, N or S in a hetero-cycle, 3- to 7-membered heterocycloalkyl(C1-7)alkyl including O, N or S in a hetero-cycle, 3- to 7-membered heterocycloalkyl(C1-7)alkoxy including O, N or S in a hetero-cycle, cyano, nitro, (C3-7)cycloalkylamino, guanidine, or urea. A method for preparing the compound of the formula(1) comprises a step of reacting a halobenzyl compound represented by the formula(3) with a pyrazole compound represented by the formula(4), each R1, R2, R3, R4, and R5 are same as defined above, and X is halogen. A pharmaceutical composition for preventing and treating inflammation related diseases such as asthma and chronic obstructive pulmonary diseases comprises the compound of the formula(1) as an effective ingredient.
Abstract:
본 발명은 화학식 1로 표시되는 신규한 2-아릴-7-(3′,4′-디알콕시페닐)-피라졸로[1,5-а]피리미딘 화합물 또는 그의 약제학적으로 허용 가능한 염, 이의 제조 방법 및 이를 유효성분으로 함유하는 것을 특징으로 하는 천식 및 만성폐쇄성 폐질환(Chronic Obstructive Pulmonary Disease)을 포함한 염증관련 질환의 치료를 위한 약제학적 조성물에 관한 것이다. [화학식1]
Abstract:
PURPOSE: Provided are 5-benzyloxymethyl-1,2-isoxazoline derivatives having an excellent herbicidal activity, its manufacturing method and herbicides containing the derivative as an active ingredient. CONSTITUTION: 5-benzyloxymethyl-1,2-isoxazoline derivative is represented by the formula(I), in which each X1, X2 and X3 represents hydrogen, methyl group, ethyl group, halogen group, methoxy group or nitro group (provided that it is an exception that X1, X2 and X3 are decimals all together); and Y1, Y2 and Y3 are respectively hydrogen or fluorine.
Abstract:
PURPOSE: Provided is N-(5-isoxazoline methyloxyphenyl)-3,4,5,6-tetrahydrophthalimide derivative which shows a great herbicidal effect only on weed without damaging crops like rice and is useful as a plant growth control agent. CONSTITUTION: A method for manufacturing N-(5-isoxazolinemethyloxyphenyl)-3,4,5,6-tetrahydrophthalimide derivative is characterized by the step of reacting a compound of the formula (2) with nitrileoxide or precursor in the presence of solvents like dichloromethane, tetrahydrofuran, benzene, ethyl ether, and C1-C4 alcohol. In the formula (1), R is an alkyl group of C1-C3, phenyl group, substituted phenyl group, cyano group, carboxylic acid group, or carboxylic acid ester group. The substituted phenyl group is a phenyl group having the same or different 1-3 substituents among an alkyl group of C1-C3, haloalkyl group of C1-C3, methylsulfonyl group, alkoxy group of C1-C3, halogen atom, cyano group, nitro group, carboxylic acid group, and carboxylic acid ester group.
Abstract:
PURPOSE: A hexahydro-1,2-benzisoxazol derivative is excellent in weeding activity and innoxious to paddy rice. CONSTITUTION: A hexahydro-1,2-benzisoxazol derivative represented by the following formula, wherein Xn is a hydrogen, a C1-C3 alkyl group, a C2-C4 alkenyl group, a C2-C4 alkynyl group, a C1-C3 alkoxyl group, a C1-C3 haloalkyl group, a C1-C3 thioalkyl group, a C1-C3 alkylsulfenyl group, a C1-C3 alkylsulfonyl group, a halogen group, a nitro group, a nitrile group, or a composite substituent thereof; Yn is a hydrogen, a C1-C6 alkyl group, a halogen group, a nitro group, a nitrile group, or a composite substituent thereof; Yn is a hydrogen, a C1-C3 alkyl group, a halogen group, a nitro group, a nitrile group, or a composite substituent thereof; and R is a hydrogen or a methyl group.
Abstract:
본 발명은 방향족 헤테로고리 아민 N-옥사이드의 제조방법에 관한 것으로서, 더욱 상세하게는 다음 구조식(Ⅲ)로 표시되는 방향족 헤테로고리 아민을 불화수소(HF) 수용액 촉매, 디메틸포름아미드와 메탄을 혼합용매 하에서 m-클로로과벤조산 산화제로 반응시켜, 짧은시간에 높은 수율로 다음 구조식(Ⅰ)로 표시되는 방향족 헤테로고리 아민 N-옥사이드를 제조하는 신규 제조방법에 관한 것이다.
상기 식에서, X 및 Y는 각각 같거나 다른 것으로서 CH 또는 N이며, R은 클로로, 카르복실산, 아미노, 옥소, C 1 ~C 4 의 알킬 또는 리보스(ribose)이며, n은 치환기 R의 갯수로서 1 내지 3의정수이다.